626. Aggressive Lymphomas: Epidemiological Excluding Prospective Clinical Trials: Poster I

The influence of racial socioeconomic and geographic disparities in the survival of patients with plasmablastic lymphoma A population based analysis from the surveillance epidemiology and end Results SEER database 2000–2022

No increase in incidence of central nervous system CNS relapse after removal of cns prophylaxis in large B cell lymphoma A real world retrospective study

Disparities in palliative care consultation among hospitalized patients with diffuse large B cell lymphoma in the United States A national analysis from 2016–2022

Real world outcomes access and role of autologous stem cell transplantation in relapsed refractory diffuse large B cell lymphoma among AYAs and non AYAs A multicenter study from Peru

Impact of radiation in limited stage diffuse large B cell lymphoma in the modern era

Academic vs community care in HHV8 DLBCL Dissecting disparities in the HIV positive population

Post transplant lymphoproliferative disorders in adult transplant recipients Preliminary results of the multicenter italian FIL PTLD study

Is autologous hematopoietic stem cell transplantation as consolidation therapy superior to chemotherapy alone in newly diagnosed intermediate high risk DLBCL patients

Estimating the United States cure adjusted prevalence of diffuse large B cell lymphoma DLBCL An epidemiological model

Facility level differences in treatment and outcomes for intravascular large B cell lymphoma A national cancer database analysis

Age at diagnosis drives molecular pathology and prognosis in diffuse large B cell lymphoma

Treatment related outcomes of very old 85 years diffuse large b cell lymphoma patients